Difference between revisions of "Template:Hallucinogens"
Jump to navigation
Jump to search
imported>David Hedlund |
imported>David Hedlund |
||
| Line 5: | Line 5: | ||
|listclass= hlist | |listclass= hlist | ||
| + | |group1= Hallucinogens | ||
| + | |list1= | ||
| + | |||
| + | {{Navbox subgroups | ||
|group1= [[Psychedelic drug|Psychedelics]]<br />''<small>[[5-HT2A receptor|5-HT<sub>2A</sub>R]] [[Serotonergic psychedelic|agonists]]</small>'' | |group1= [[Psychedelic drug|Psychedelics]]<br />''<small>[[5-HT2A receptor|5-HT<sub>2A</sub>R]] [[Serotonergic psychedelic|agonists]]</small>'' | ||
|list1= | |list1= | ||
| Line 259: | Line 263: | ||
* [[Tenocyclidine]] | * [[Tenocyclidine]] | ||
* [[Tiletamine]] | * [[Tiletamine]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|group4= Others | |group4= Others | ||
|list4= | |list4= | ||
| Line 435: | Line 432: | ||
}} | }} | ||
| − | + | }} | |
| − | |||
| − | + | |group2= Psychological dependence | |
| + | |list2= | ||
| + | |||
| + | {{Navbox subgroups | ||
| + | |||
| + | |group1= [[Morphinan]]s | ||
| + | |list1= | ||
| + | * [[Dextrallorphan]] | ||
| + | * [[Dextromethorphan]] | ||
| + | * [[Dextrorphan]] | ||
| + | * [[Racemethorphan]] | ||
| + | * [[Racemorphan]] | ||
| + | |||
| + | }} | ||
| + | |||
| + | |group3= [[Entheogen#Controversial entheogens|Controversial halluciongens]] | ||
| + | |list3= | ||
| + | {{Navbox subgroups | ||
|group1= [[Dopamine receptor D2|D<sub>2</sub>R]] [[Dopamine agonist|agonists]] | |group1= [[Dopamine receptor D2|D<sub>2</sub>R]] [[Dopamine agonist|agonists]] | ||
|list1=<small>Indirect D<sub>2</sub> agonists, such as [[dopamine reuptake inhibitor]]s ([[cocaine]], [[methylphenidate]]), [[releasing agent]]s ([[amphetamine]], [[methamphetamine]]), and [[Precursor (chemistry)|precursors]] ([[L-DOPA|levodopa]]).</small> | |list1=<small>Indirect D<sub>2</sub> agonists, such as [[dopamine reuptake inhibitor]]s ([[cocaine]], [[methylphenidate]]), [[releasing agent]]s ([[amphetamine]], [[methamphetamine]]), and [[Precursor (chemistry)|precursors]] ([[L-DOPA|levodopa]]).</small> | ||
| Line 463: | Line 476: | ||
** [[Chlorofluorocarbon]]s | ** [[Chlorofluorocarbon]]s | ||
** [[Chloroform]] | ** [[Chloroform]] | ||
| + | }} | ||
}} | }} | ||
Revision as of 03:15, 23 June 2014
}} Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Hallucinogens|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Hallucinogens|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Hallucinogens|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.